Several studies have been conducted focusing on marijuana’s potential to treat and ease symptoms associated with multiple sclerosis – a disease that affects the central nervous system, often causing daily pain and difficulty moving, speaking, and swallowing. A new study adds even more insight into how MS patients can use marijuana, finding that cannabinoids within the vilified healing plant can help treat multiple sclerosis-like diseases by preventing inflammation in the brain and spinal cord.
The study, published in the Journal of Neuroimmune Pharmacology, set out to see if the anti-inflammatory compounds in marijuana known as tetrahydrocannabinol (THC) and cannabidiol (CBD) could be used to treat the inflammation associated with MS.
“Our study looks at how compounds isolated from marijuana can be used to regulate inflammation to protect the nervous system and its functions,” explains Dr. Ewa Kozela. “Inflammation is part of the body’s natural immune response, but in cases like MS, it gets out of hand.”
Using immune cells isolated from paralyzed mice, the researchers used THC or CBD to determine how these compounds affected the production of inflammatory markers, specifically one called interleukin 17 (IL-17). This inflammatory marker is strongly associated with MS and is harmful to nerve cells.
“The presence of CBD or THC restrains the immune cells from triggering the production of inflammatory molecules, and limits the molecules’ ability to reach and damage the brain and spinal cord,” wrote the researchers, finding the amount of IL-17 was far fewer in mice treated with the cannabis compounds.
This isn’t the first clue that marijuana could hold treatment options for inflammatory conditions. It’s already being used, legally or otherwise, by countless people for the treatment of pain and muscle stiffness associated with inflammation.
Likewise, it isn’t the first study looking at the marijuana-MS connection. In 2011, a study found that CBD helps treat MS symptoms in mice by preventing immune cells from attacking nerve cells in the spinal cord. Another study coming to similar conclusions found that:
“The study met its primary objective to demonstrate the superiority of CE (cannabis extract) over placebo in the treatment of muscle stiffness in MS. This was supported by results for secondary efficacy variables. Adverse events in participants treated with CE were consistent with the known side effects of cannabinoids. No new safety concerns were observed”
Mice suffering from MS-symptoms were treated with CBD and went from being partially paralyzed and immobile to walking with a limp. These mice had less inflammation in their spinal cord than those untreated.
Research on CBD is particularly exciting because it offers the benefits of cannabis without the psychoactive effects. In other words, when isolated from other compounds in the plant, it won’t get you “high”. Add to this the fact that there are few, if any, known side effects of treating with CBD and this and other studies are extremely promising.
“When used wisely, cannabis has huge potential,” Dr Kozela says. “We’re just beginning to understand how it works.”
Over the past few years, an interesting pattern has emerged, where political supporters of genetically engineered (GE) foods are feasting on organics, while promoting unlabeled GE foods for everyone else.
Most recently, Mother Jones discussed how Presidential hopeful Mitt Romney – whose ties to Monsanto go back to the late 1970’s when GE crops were still in the R&D phase – reportedly makes sure his own meals are nothing but organic…
According to Peter Alexander of MSN Today:
“On Romney Air, or Hair Force One – as Reuters’ Steve Holland like to call it – Mitt Romney has his own galley in ‘forward cabin.’ And, while I’ve never been invited up front, sources close to the campaign tell me the shelves are stocked with a wide variety of healthy fare. Kashi cereals, hummus, pita, as well as organic applesauce.
Everything’s organic, I’m told, including the ingredients to Romney’s favorite, peanut butter and honey sandwiches.”
Even more interesting, in a 2002 article about Romney’s wife, Ann, she credits a combination of organic foods and holistic medicine for turning her health around after she was diagnosed with multiple sclerosis in 1998. The profile reads in part:
“…She was 49 at the time, and the disease was progressing rapidly, she says, prompting the doctors to put her on steroids, which made her so sick she could barely get out of bed. ‘They were killing me,’ she says of the treatment. ‘You have bone loss; they are so bad for you.’
Mrs. Romney was introduced to several practitioners of holistic medicine, who persuaded her to adopt alternative therapies. She now eats organic foods and very little meat. She practices reflexology and undergoes acupuncture treatments. She credits the lifestyle with turning her health around…
‘Everyone has to find their own way,’ she says. ‘Three years ago I was really, really sick and not able to function at all. A lot of the symptoms are [now] gone…'”
Mrs. Romney isn’t the only success story in which food played a center role in beating multiple sclerosis (MS). Last year I posted an article about Dr. Terry Wahls, who reversed MS after seven years of deterioration on the best conventional treatments available, simply by changing her diet.
Wouldn’t it be a nice change of pace if our agricultural authorities, not to mention our President, could reach into their hearts and find the humanity to fight for everyone’s right to eat wholesome food that doesn’t contain foreign DNA, built-in pesticides, and an inordinate amount of synthetic chemicals so that diseases such as MS and cancer could be curtailed before they even get a foothold?
If GE Foods are So Great, Why Won’t the Elite Eat Them?
While Obama has been a huge supporter of Big Biotech during his term, Romney is just as “tight” with Monsanto, having actually successfully guided the company out of lawsuits with Congress in the shameful aftermath of Agent Orange (a Monsanto creation, which was supposed to be harmless to everything except vegetation), and heinous chemical dumping incidents in Missouri and Alabama.
He’s also in favor putting the “Monsanto rider” provision in the 2012 Farm Bill – a rider that would prevent a federal court from putting in place court-ordered restrictions on a GE crop, even if the approval were fraudulent or involved bribery, among other things.
Unfortunately, Mitt Romney is just one in a line of politicians who support and promote GE foods as being just as safe and “natural” as conventional foods while privately serving up nothing but organic for their own families. President Obama, as his predecessors George W. Bush and Bill Clinton, have all reportedly insisted on an organic diet.
Mother Jones writes:
“What’s my evidence that the Clintons and Bushes ate organic? Get this, from someone who knows – Walter Scheib, who served as White House executive chef during the Clinton and Bush years:
‘From 1994 to 2005 I was the executive chef at the White House. This offered me not only the personal honor of serving two unique and interesting first families, but the professional challenge of fulfilling Hillary Clinton’s mandate of bringing contemporary American cuisine and nutritionally responsible food to the White House.’
This meant that nearly all the product used was obtained from local growers and suppliers. There was a small garden on the roof of the White House where produce was grown. The ethic of the purchasing and the cooking at the White House under my direction and under the continuing direction of [current Obama White House executive chef] Cris Comerford is one of respect for the pedigree of the product and manner it is grown, gathered, raised or caught.
The Clinton and Bush families dined regularly on organic foods. Both wagyu and grass-fed beef were frequently used.”
Scheib was again quoted in a 2009 article by Think Progress, stating that Laura Bush was “adamant that in ALL CASES if an organic product was available it was to be used in place of a non-organic product.” Meanwhile, the article lists a number of atrocious food policies instituted by her husband. Who knows, perhaps she was so adamant about organics because she knew the quality and safety of conventional food was rapidly going down the toilet?
Guess Who Said: “Everything That’s in a Bottle or Package is Like Poison in a Way That Most People Don’t Even Know”
The Obama White House may be even more progressive about healthful dining than previous Presidents. In a 2008 article about First Lady Michelle Obama, published in The New Yorker:
“…One morning, during a roundtable at Ma Fischer’s, a diner in Milwaukee, Elizabeth Crawford, a recently divorced caterer with two children, brought up the subject of the eating habits of American families. ‘I really, really hope that Barack will jump on that,’ she said.
Then, having given thoughtful but boilerplate responses most of the morning, [Michelle] Obama suddenly departed from her script. It was the most animated I saw her on the campaign trail. ‘You know,’ she said, ‘in my household, over the last year we have just shifted to organic for this very reason. I mean, I saw just a moment in my nine-year-old’s life – we have a good pediatrician, who is very focused on childhood obesity, and there was a period where he was, like, ‘Mmm, she’s tipping the scale.’
So we started looking through our cabinets… You know, you’ve got fast food on Saturday, a couple days a week you don’t get home. The leftovers, good, not the third day! …So that whole notion of cooking on Sunday is out. … And the notion of trying to think about a lunch every day! …So you grab the Lunchables, right? And the fruit-juice-box thing, and we think – we think – that’s juice.
And you start reading the labels and you realize there’s high-fructose corn syrup in everything we’re eating. Every jelly, every juice. Everything that’s in a bottle or a package is like poison in a way that most people don’t even know…”
Yes, high-fructose corn syrup is one of the most atrocious ingredients in the American food supply today in terms of what it does to your health. Not only is fructose a major contributor to metabolic syndrome, diabetes and obesity, the vast majority of it is also derived from genetically engineered corn, which has its own increasingly well-documented ill health effects. Most recently, the world’s first lifetime feeding study using Monsanto GE corn found it caused massive breast tumors, kidney and liver damage, and other serious health problems.
Michelle Obama is certainly not the only one who has referred to high-fructose corn syrup as a poison. According to Dr. Robert Lustig, excess fructose does act like a toxin in your body, and Dr. Don Huber has spoken out about the two-fold toxic effects of GE crops: 1) due to the genetic alteration of the plant itself, and 2) the glyphosate sprayed on GE Roundup Ready crops.
President Obama Aware of Issue But Doing Nothing About it
Sadly, while the Obama’s are undoubtedly well aware of the health dangers of processed foods in general and genetically engineered foods specifically, their personal belief system has not filtered into the food policies that affect the rest of the population.
On the contrary, the President has spent the last four years appointing one Monsanto shill after another into key federal positions that wield near-absolute power over agricultural issues. Mrs. Obama’s efforts to promote organic foods, which included a much publicized White House organic garden, were also quickly tempered and toned down by a personal visit from The Mid America CropLife Association, an agribusiness media group, who “urged the first lady to give conventional agriculture equal time,” according to a 2009 Politico article.
Topping it all off, the President has also completely ignored his pre-election promise to IMMEDIATELY label GE foods, should he win, “because Americans should know what they’re buying.”
Well, it’s become abundantly clear that Big Biotech and their political lackeys will not even allow us to make an informed decision on this issue by reading our own food labels. And you’d have to be supremely naïve to not question the absurd dichotomy between public policies on GE and organic foods, and the private decisions made by those in charge and “in the know.”
Monsanto Runs and Regulates US Agriculture
In the first three years of the Obama Administration, 10 different genetically engineered crops, and even a genetically modified animal, have been approved by the US Department of Agriculture (USDA), according to Food & Water Watch. All without a single shred of proof that these foods are actually safe for long-term consumption (or in the case of today’s children – lifetime consumption). Could this have anything to do with the fact that highly influential people within the USDA were previous employees of, or have other personal ties to, Monsanto?
The Secretary of Agriculture is Tom Vilsack, a strong Monsanto supporter selected by President-elect Obama in 2008. As governor of Iowa, Vilsack frequently traveled in Monsanto’s private jets, and was named Governor of the Year by the Biotechnology Industry Organization.
The director of the National Institute of Food and Agriculture is Roger Beachy, a former director of the Monsanto Danforth Center.
The General Counsel for the USDA is Ramona Romero, who came straight from DuPont, another major biotech company with GE crop patents, where she held a number of key positions, including Corporate Counsel for complex commercial and antitrust litigation, and Corporate Counsel and Manager of Operations and Partnering.
Even the Secretary of State, Hillary Clinton, has old ties to Monsanto via the Rose Law firm.
Getting the picture? The US Food and Drug Administration (FDA) and other federal agencies are similarly stacked with former Monsanto employees. Likewise, when it comes to selecting which Presidential candidate might be better for organic foods and our agriculture system, both Romney and Obama’s actions speak louder than words. They do one thing privately, and “sell” another agenda to the public. Neither of them is a champion for Real Food in the US, and both of them cater and yield to the wills of multinational food and biotech companies.
Monsanto VP Now US Food Safety Czar – What’s Wrong With This Picture?
In 2009, President Obama appointed former Monsanto VP for Public Policy, Michael Taylor, as a senior adviser for the FDA, turning a deaf ear to the loud protests from consumer groups. Taylor is currently serving as the deputy commissioner for foods at the FDA – a position that includes ensuring food labels contain clear and accurate information. He also oversees strategy for food safety, and planning new food safety legislation.
To say he’s a fox guarding a hen house would be an understatement. This sentiment is shared by most people who are even remotely aware of food safety issues. At the time of Taylor’s appointment, GE expert Jeffrey Smith commented:
“The person who may be responsible for more food-related illness and death than anyone in history has just been made the US food safety czar. This is no joke.”
Now, the opposition is gaining steam yet again with an online petition13 calling for Taylor’s removal.
“President Obama, I oppose your appointment of Michael Taylor. Taylor is the same person who was Food Safety Czar at the FDA when genetically modified organisms were allowed into the U.S. food supply without undergoing a single test to determine their safety or risks. This is a travesty,” the petition reads.
Passing Prop 37 is Key to Expanding Sustainable Agriculture in North America
Organic foods specifically prohibit genetically engineered ingredients along with synthetic agricultural chemicals, and eating organic is essentially the only way to ensure you’re not accidentally consuming GE foods, since the US still does not require such ingredients to be labeled.
So what’s with the double standard?
Is genetically engineered food the “cake” fit only for the paupers of the 21st century? Heck, even the staff cafeteria at Monsanto’s UK headquarters reportedly banned GE foods from the menu back in 1999.
So really, why are the elite making organic foods a priority for their own families? And why won’t they support labeling, so the rest of us can make an informed decision about the foods we eat? And why are they imposing regulations that limit the availability of organically- and/or locally-grown foods for so many communities?
It’s quite evident that we have no real champions for food safety and labeling of genetically engineered foods within the federal government. But right now we do have a great opportunity to change this situation by circumventing Monsanto’s posse entirely.
Twenty-four U.S. states have, as part of their state governance, something called the Initiative Process, where residents can bring to ballot any law they want enacted, as long as it has sufficient support. California has organized such a ballot initiative, known as Proposition 37, to get labeling for genetically engineered foods sold in their state.
Although many organic consumers and natural health activists already understand the importance of Proposition 37, it cannot be overemphasized that winning the battle over Prop 37 is perhaps the most important food fight Americans – not just Californians – have faced so far. But in order to win this fight for the right to know what’s in our food, we need your help, as the biotech industry will surely outspend us by 100 to 1, if not more, for their propaganda. Please remember, the failure or success of this ballot initiative is wholly dependent on your support and funding! There are no major industry pockets funding this endeavor. In order to have a chance against the deep pockets of Big Biotech and transnational food corporations, it needs donations from average citizens.
So please, if you have the ability, I strongly encourage you to make a donation to this cause. You can also contact EVERY person you know that lives in California and encourage them to view some of these videos and get educated on the issues so they can avoid succumbing to the propaganda, as Monsanto and company are paying tens of millions of dollars to deceive the voters in California. We need EVERY vote we can to win next month. The election is only FOUR weeks away.
It’s important to realize that getting this law passed in California would have the same overall effect as a national law, as large companies are not likely going to label their products as genetically engineered when sold in California (the 8th largest economy in the world), but not when sold in other states. Doing so would be a costly PR disaster. So please, I urge you to get involved and help in any way you can, regardless of what state you live in.
Whether you live in California or not, please donate money to this historic effort, through the Organic Consumers Fund.
If you live in California and want to get involved, please contact CARightToKnow.org. They will go through all volunteer requests to put you into a position that is suitable for you, based on your stated interests and location.
No matter where you live, please help spread the word in your personal networks, on Facebook, and Twitter. For help with the messaging, please see CARightToKnow.org.
Talk to organic producers and stores and ask them to actively support the California Ballot. It may be the only chance we have to label genetically engineered foods.
Low blood levels of vitamin D are associated with an increased number of brain lesions and signs of a more active disease state in people with multiple sclerosis (MS), a new study finds, suggesting a potential link between intake of the vitamin and the risk of longer-term disability from the autoimmune disorder.
But researchers, led by Ellen M. Mowry, M.D., M.C.R., an assistant professor of neurology at the Johns Hopkins University School of Medicine and principal investigator of a multicenter clinical trial of vitamin D supplementation in MS patients, caution that more research is needed to determine if large doses of vitamin D help without harming MS patients.
Mowry’s study, conducted mostly when she worked at the University of California, San Francisco, shows a strong correlation between vitamin D levels in the body (measured through blood samples) and the characteristic brain lesions of MS as measured with MRI images. Results were described in the August issue of Annals of Neurology.
“Even though lower levels of vitamin D are associated with more inflammation and lesions in the brain, there is no evidence that taking vitamin D supplements will prevent those symptoms,” she says “If we are able to prove that through our currently-enrolling trial, it will change the way people with multiple sclerosis are treated.”
In people with MS, the body’s immune system attacks the coating of nerve fibers in the brain and spinal cord. The coating, made of a fatty protein called myelin, insulates the nerves and helps them send electrical signals that control movement, speech and other functions. When myelin is attacked, inflammation interferes with message transmission, activity that shows up on an MRI as lesions, which look like white spots.
In the most common form of MS, called relapsing-remitting MS, patients may at times have no symptoms, but at other times may suffer from “attacks” (or “relapses”) of symptoms such as blurred vision, numbness and weakness. There is currently no cure for the disease but there are medications to help reduce the number of attacks and to help reduce symptoms left over if a person hasn’t fully recovered from an attack.
For the study, Mowry and her colleagues used data from a five-year study of 469 people with MS. Each year, beginning in 2004, researchers drew blood from, and performed MRIs on, the brains of study participants, looking for both new lesions and active spots of disease, which lit up when a contrast dye was used. The investigators found that each 10-nanograms-per-milliliter increase in vitamin D levels was associated with a 15 percent lower risk of new lesions and a 32 percent lower risk of spots of active disease, which require treatment with medication to reduce likelihood of permanent nerve damage. Higher vitamin D levels were also associated with lower subsequent disability.
The impact of vitamin D levels remained even after other factors that can affect disease progress were accounted for, including smoking status, current MS treatment, age and gender.
At least early in MS, the more new lesions and active spots of disease, the more likely a patient is to develop longer-term disability, Mowry says. Some people with relapsing-remitting MS progress to a more serious form due to damage of the underlying nerve cells.
From one year to the next, Mowry says, she and her colleagues were able to predict the appearance of new lesions and active disease spots based on vitamin D levels from the year before. Active and new lesions indicate that a patient’s MS is not under optimal control.
Previous studies have indicated that lower vitamin D levels are associated with increased relapse risk in certain MS patients. Those studies relied on patients to report their attacks, which is sometimes a less reliable assessment than MRI.
Some patients already take extra vitamin D because of publicity about earlier studies. However, Mowry says that there is no research proving vitamin D alleviates symptoms or suggesting what dose is best or safest. And nothing is known about whether vitamin D can prevent the autoimmune disorder, she says.
“People think vitamin D is available over the counter so it must be safe,” Mowry says. “But vitamin D is a hormone, and any medication really does need to be thoroughly tested before we definitely recommend it. That’s the main reason why we are now performing a randomized trial of vitamin D supplementation. People with MS should talk with their doctors about the pros and cons of taking vitamin D before starting the supplement.”
Are pesticide resistant seeds responsible for cell signaling malfunctions?
The August 14th, 2010 issue of Science News, ”Separating wheat from chaff in celiac disease”, reported that a research team led by gastroenterologist Robert Anderson of the Walter and Eliza Hall Institute of Medical Research in Parkville, Australia, had identified specific triggers (gluten sensitivities) associated with celiac disease.
These following observations are based on the mathematical matrix of BioAcoustic Biology developed over the last twenty years by the Sound Health Research Center located in Albany, Ohio, USA. The system allows for the evaluation of any aspect of the body and biochemistry in terms of numeric pathways, aka Frequency Equivalents™.
Research efforts at the Institute of BioAcoustic Biology often evaluate clients who exhibit gluten sensitivity along with a myriad of associated diseases. In light of this new information it was imperative that this data be added to their analytical software databases. The three proteins identified by the Anderson study were translated into BioAcoustic bio-frequency biomarkers*. The resulting numeric matrix showed that the metabolic pathways influenced by these proteins were linked to nearly all systems of the human body; causing immune distortion, acute cellular inflammation and disruptions in cell communication.
The original article listed three proteins, w-5 gliadin (wheat), g-3 hordein (barley) and g secalins (rye) that were implicated in the production of specific anti-gliadin antibody reactions. These proteins, which have been proven to be responsible for allergic reactions, are associated with grain glutens from which they are derived.
Patent records indicated many grains seeds being produced for market are GMO’s developed and patented by a multinational agricultural biotech conglomerate that is attempting to make their grains impervious to weed killers. Could this confirm that the present day epidemic of grain related sensitivities/allergies stem from laboratory modified seeds?
These distorted, allergy causing, “engineered” grains are being used to create foods that we eat everyday; bread, cereals, chips, crackers, pastry, seasonings, even some packaged chip products contain gluten. BioAcoustic Biology matrix correlations revealed how thoroughly our health is being negatively influenced by these genetically modified foods (GMO’s).
Further investigation revealed that the engineered grains contain two substitutions that distorted the way the body processes two sulfur rich amino acids: proline and glutamine. Disturbances in these amino acid substitutions result in the impedance of the methylation of these two essential nutrients.
BioAcoustically speaking, Glutamine distortions seem to be the most destructive. The enzyme required to utilize glutamine is glutamate decarboxylase (GAD). Glutamate is a key molecule in cellular metabolism and the most abundant excitatory neurotransmitter in a vertebrate nervous system.
In mammals, GAD exists in two isoforms encoded by two different genes – Gad1 and Gad2. GAD1 and GAD2 are expressed in the brain where GABA is used as a neurotransmitter; GAD2 is also expressed in the pancreas.
This led to an evaluation of the GAD genomes and what happens when these genes are activated:
Glutamate decarboxylase aka glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the decarboxylation (part of the process of breaking down for use by the body) of glutamate to GABA (gamma aminobutyric acid) and CO2.
GABA is a natural tranquilizer and an important inhibitory neurotransmitter that helps regulate neuron activity and the body’s nanosensors. Starting with the GAD enzyme response and moving toward GABA in conjunction with the active form of B6 (PLP), the nanotransmitters of the body are created and regulated. The movement of electrical energy and hence magnetic potential within the body are controlled by these nanotransmitters.
GAD uses PLP (pyridoxal 50-phosphate) as a cofactor. PLP was granted a patent by the US government patent office to the Canadian company, Medicure. PLP is now under the control of the pharmaceutical industry and its lack is often associated with blood clotting distortions, migraines, neural disorders and seizures.
Nanotransmitters produced in conjunction with GAD metabolism show direct associations with a multitude of diseases: diabetes, autism, arthritis, Parkinson’s, ALS, Multiple Sclerosis, joint pain and deterioration, auditory disorders, Celiac Disease, Crohns, Irritable Bowel syndrome, diverticulitis, schizophrenia, bipolar and anxiety disorders, aspartame sensitivity, MSG reactions, Lupus, Fibromyalgia, depression, seizures, brain signaling, the use of calcitonin (cancer related), histidine function (seasonal allergies), cellular inflammation and vaccination reactions.
Of particular importance is GAD’s involvement with cancer via Calcitonin, a 32–amino-acid peptide/hormone that participates in calcium and phosphorus metabolism. BioAcoustically speaking, calcitonin is a major player in the role of how the body handles any cancer threat.
Parkinson’s is an incurable, debilitating disease that also shows GAD involvement. The activity of glutamic acid decarboxylase (GAD), the enzyme involved in formation of the inhibitory neurotransmitter γ-aminobutyric acid (GABA), was studied in autopsy brain samples from six Parkinson’s patients and 13 controls. The activity of GAD was significantly reduced in brain samples of patients with Parkinson’s disease, being about 50 percent of that in controls. Moreover, levodopa treatment showed a tendency to increase the activity of GAD. The results suggest the involvement of GABA neurons in Parkinson’s disease.
A search of the GAD literature stated that acetylcholine, γ-aminobutyric acid, dopamine, calcitonin gene-related peptides, choline acetyltransferase and enkephalins are involved with the metabolism of GAD. It would be important to include these biochemicals when testing subjects for GAD presence and methylation.
Glutamate is the same Frequency Equivalent* as aspartame and is part of MSG (mono-sodium glutamate). James Oschman in his publication, Energy Medicine, states that cells emit frequency-based signals as a request for needed biochemicals to gather at the site where they are needed. Since Glutamate and Aspartame are the same frequency, this may explain why Aspartame has been implicated in so many muscle and joint disorders.
MSG is also used as a stabilizer in some vaccines. This could account for the reported increase in autism associated vaccination damage.
“This may be one of the decade’s most important ‘connections’ between food and genetics. By showing the frequency relationships among substances normally found in healthy people, you have confirmed that the potential for GMO harm is very real,” states Ralph Fucetola, JD and health freedom advocate.
Sharry Edwards, the recognized pioneer of this emerging technology states, “I expect this information will be the impetus that opens the world to the potential of BioAcoustic Biology and the hope of allowing access to Self Health care via easy-to-use software; even after the appearance of a disease process”.
From the original Science News article:
“Three protein fragments are looking like the guilty parties in celiac disease, an intestinal ailment that affects as many as one in 133 people in the United States. These partial proteins, or peptides, are the part of gluten in wheat, rye and barley that triggers the immune systems of celiac patients, damaging the small intestine. An Australian research team reports the new findings in the July 21 Science Translational Medicine.”
“This is an impressive and very comprehensive study,” says immunologist Ludvig Sollid of the University of Oslo. “The authors find that most celiac patients make a response to these three gluten peptides.”
Questions: Are GMO producers aware of the damage to health that is being caused? Shouldn’t those with cell signaling issues be warned about ingesting these glutens? Why are GMO producers and the US government boldly attempting to prevent package warnings that would notify people that they were eating GMO products? Is it greed, ignorance or a misguided attempt to improve our food supply that is in fact poisoning our food, our population, and our genetic pool? Is this assault on our food supply intentionally creating a future that will keep us ill and medication dependent?
Interferon beta, the most widely prescribed medication used to treat multiple sclerosis (MS), has not shown any effect in delaying the disease’s progression, according to a new study.
“Treatment with beta interferon was not associated with a delay in progression to disability,” senior researcher Dr. Helen Tremlett, an associate professor at the University of British Columbia, told WebMD. “It may be that in subgroups of patients these drugs do slow disease progression, but we were not able to show this.”
Researchers at the University of British Columbia collected information on 868 multiple sclerosis patients who had taken interferon beta and 1,788 patents who had not, from 1985 to 2008. Out of the group of patients who were not medicated with interferon beta, they were split into people who were able eligible for the drug but did not receive it (untreated) and people who fit the criteria for the drug, but it was not yet available when they needed it (historically untreated).
Researchers discovered that those who took the drug were no less likely to have long-term disability than those who didn’t take the drug, when looking at a standard test to measure disability progression in MS.
“It dampens somewhat the enthusiasm for so-called first-line therapies,” Ludwig Kappos of University Hospital in Basel, Switzerland and author of an editorial that accompanied the study, said to Businessweek.
The study was published on July 18 in The Journal of the American Medical Association.
Researchers used a metric known as a Expanded Disability Status Scale (EDSS) to judge how far the disease had progressed in their participants. Those who scored a 6 – meaning they needed a cane to walk 330 feet or 100 meters – were considered to have a disease that progressed. Out of the subjects who took interferon beta, 10.8 percent scored a 6. Out of the subjects who were untreated, only 5.3 percent and 23.1 percent of the historically untreated group reached that same score.
Previous studies have reportedly shown that interferon beta does help stall disease progression, but researchers said that the methodology was flawed through small sample sizes, poor follow-up or included patients who were too ill to start taking medication in the control group, according to TIME.
Multiple sclerosis is a chronic autoimmune disease that attacks the central nervous system often leading to disability, according to the National MS Society. It uses the body’s own defense system to attack myelin, the fatty substance that protects the nerve fibers in the central nervous system. This causes the fibers to form scar tissue – known as sclerosis – disrupting the messages traveling from the brain and spinal chord to other parts of the body.
The National MS Society adds that most people are diagnosed between 20 and 50, and while it is not considered a fatal disease, it can present many difficulties in the lives of those diagnosed. About 400,000 Americans have MS, and about 2.1 million people worldwide are affected. A person is diagnosed every hour.
There are four types of MS. Interferon beta drugs are used to treat the relapsing-remitting form of the disease, which is the initial diagnosis for 85 percent of MS patients, the National MS Society reports. People with relapsing-remitting MS often have attacks – called relapses, flare-ups or exacerbations – that show worsening neurological function.
This doesn’t mean that MS patients should stop taking interferon beta. It has been shown to benefit MS patients in other ways, senior author Helen Tremlett told the New York Times.
“These drugs were licensed because they reduce relapse and have a better outcome with lesions,” she said. “That has not changed.”
LDN has been shown to halt disease progression in Crohn’s disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson’s disease and amyotrophic lateral sclerosis (ALS). LDN is a naturally-acting immune modulator that is cheap and effective for use in treating autoimmune diseases, cancers and other diseases. The only significant side effect is “wild dreaming”. – Ed
Naltrexone is the generic name for a drug, approved by the FDA in 1984, used to treat alcohol and opioid addiction. Opioids are generally pain-management agents such as morphine, codeine, oxycodone, and fentanyl. Opioids also include heroin and methadone, as well as our own naturally occurring endorphins.The first study of LDN published in a US-based medical journal would come in 2007, with Dr. Jill Smith’s article in the Low-dose naltrexone therapy improves active Crohn’s disease” (e-published in January, print published in April). Smith and her team found that 67% of the patients went into remission and fully 89% showed some therapeutic benefit. This encouraging work led to an NIH grant and a Phase II placebo-controlled clinical trial, currently in progress.
In September, 2008, results were published for a Phase II clinical trial in Italy in which LDN was used to combat multiple sclerosis (MS). Again, the results were highly promising. Since MS is thought to result from an autoimmune process whereby T cells mistake myelin—the coating around nerve cell fibers in the brain and spinal chord—for a foreign invader and attack it, many assumed that MS was the consequence of an overactive immune response. These results, though, would argue against that theory.
LDN is inexpensive with virtually no harmful side effects. However, since it is no longer a proprietary drug, the pace of rolling out clinical trials for the off-label effects described in this article will probably be slow, as will its acceptance by mainstream medicine. Still, there is nothing to prevent a patient from taking an FDA approved drug for an off-label indication, and this practice goes on all the time.